The mortality rate and incidence of re-hospitalization for HF in MSC patients showed a trend toward reduction compared to the control group, although the differences were not statistically significant because of the low event rate.
← all excerpts
Mesenchymal Stem Cell Therapy for Ischemic Heart Disease: Systematic Review and Meta-analysis.
1
—
—